|
生物医药卫生领域发展重点明确
稿源： 健康报网 编辑： 杨晨雨 2011.07.19
《国家“十二五”科学与技术发展规划》发布生物医药卫生领域发展重点明确
本报讯 (记者王 丹)日前，由科技部会同国家发改委、财政部、教育部、中科院、中国工程院、自然基金会、中国科协等有关部门和单位，共同编制完成的《国家“十二五”科学与技术发展规划》正式发布。其中，生物医药卫生领域的相关工作在规划中占重要地位。
研制30个创新药物
《规划》提出，“十二五”期间，将重点突破一批药物创制关键技术和生产工艺，研制30个创新药物，改造200个左右药物大品种，完善新药创制与中药现代化技术平台，建设一批医药产业技术创新战略联盟，基本形成具有中国特色的国家药物创新体系。
“艾滋病和病毒性肝炎等重大传染病防治”则重点围绕艾滋病、病毒性肝炎、结核病等重大传染病，突破检测诊断、监测预警、疫苗研发和临床救治等关键技术，研制150种诊断试剂，其中20种以上获得注册证书；10个以上新疫苗进入临床试验。到2015年，重大传染病的应急和综合防控能力显著提升，有效降低艾滋病、病毒性肝炎、结核病的新发感染率和病死率。
生物技术纳入战略性新兴产业
在《规划》中，生物产业成为7项“十二五”期间优先发展的战略性新兴产业之一。将重点突破药物创制、新型疫苗、疾病早期诊断等关键技术和生产工艺，获得40项拥有自主知识产权的新型药物产品，获得关键专利700项~800项，形成关键生产工艺及相关标准100项，建设抗体、疫苗等新型生物医药开发及产业化基地30个~40个，培育10个龙头企业。
重点突破生物医用材料及器械的优化设计和评测等关键技术。研发新型骨及口腔植入体、可降解血管支架、适宜国人的人工关节、创面快速无痕修复材料等重大产品20项以上，获得关键专利50项以上。
重点开展医学影像、医用电子、微创介入、放射治疗、激光治疗等高端医疗设备研究，研制生产15项左右中高端产品，培育20个以上具有较强自主创新能力的骨干企业。
提升人口健康成为民生科技主要内容
《规划》提出，大力加强民生科技。其中，卫生与全民健康、临床医学/转化医学研究、中医药、食品安全4项内容占民生科技示范重点项目的50%。
在临床医学/转化医学研究方面，要以人类发病率高、死亡率高的重大疾病为重点。在中医药方面，要重点突破中药材规范化种植、中药配方颗粒质量标准、中药药效物质研究及中药质量评价等关键技术。重点支持100余个常用中药材品种开展中药规范化种植研究和10余个中药材大品种的深度开发，开展8个~10个新药品种的研发、30个传统中药大品种的二次开发，促进3个~5个中药品种进入国际市场。
在食品安全方面，要加强风险监测与评估、食品污染物高新检测技术与装备研发；开展从农田到餐桌的食品安全科技示范；推动建立食品安全突发事件监控与预警立体交叉网络信息系统。
干细胞等基础研究力争5年取得重大突破
《规划》提出，国家将大力推动实施蛋白质研究、发育与生殖研究、干细胞研究等6个重大科学研究计划，力争在未来5年内取得重大突破。重点支持非传染性慢性复杂疾病机理及其防治、传染性疾病致病机理及其防治、计划生育与生殖健康、灾害医学、我国不同民族疾病易感性、衰老和衰老相关疾病、中医药、人与环境相互作用等领域的基础研究。
将重点研发基因组学及新一代测序技术、蛋白质组学技术、干细胞技术等；大力开发诊断试剂、疫苗、灵长类疾病动物模型及血液制品、组织工程技术和产品等；建立基因测序、蛋白质组学、转化医学等研发平台、抗体库和疫苗研发基地等。
艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复
 |
| 图示∶2011年5月正式出版的《中国特色医疗金鉴》登载的刘君主任及其机构事迹 |
| |
|
|
The development of biomedical health focused
Is the source: Health News Editor: Yang Chenyu 2011.07.19
"National" five "Science and Technology Development Planning" published developments in the field of biological medicine and health focused
(Reporter Wang Dan) Recently, the Ministry together with the State Development and Reform Commission, Ministry of Finance, the Ministry of Education, Chinese Academy of Sciences, Chinese Academy of Engineering, Fund for Nature, China Association for Science and other relevant departments and units together to complete the preparation of "State" five-second "Science and Technology Development Planning" was released. Among them, the biomedical health-related work an important role in the planning.
Developed 30 new drugs
"Plan" put forward "five-second" period, will focus on breakthroughs in key technologies and create a group of drug production process, developed 30 new drugs, about 200 transformed a large variety of drugs, improve the drug technology platform to create and modernization of Chinese medicine, the construction of a approved pharmaceutical industry technology innovation strategic alliance with Chinese characteristics has basically taken shape national drug innovation system.
"AIDS and viral hepatitis and other major infectious diseases" is the focus on AIDS, viral hepatitis, tuberculosis and other major infectious diseases, breakthrough detection and diagnosis, monitoring and early warning, vaccine development and clinical treatment and other key technology, developed 150 kinds of diagnostic reagents, which 20 or more receive a certificate of registration; more than 10 new vaccines into clinical trials. By 2015, major infectious diseases prevention and control of emergency response and ability to significantly improve overall, reduce AIDS, viral hepatitis, tuberculosis prevalence and mortality of new hair.
Biotechnology into strategic emerging industries
"Planning", the bio-industry has become a 7 "five-second" priority during the development of strategic new industries. Will create major breakthroughs drugs, new vaccines, disease diagnosis and other key technologies and production processes, access to 40 new drugs with independent intellectual property products, access to key patents 700 ~ 800, the formation of the key production processes and related standards 100, construction of antibody, vaccine development and new bio-pharmaceutical industrial base 30 ~ 40, nurture 10 enterprises.
Breakthroughs in biomedical materials and equipment to optimize the design and evaluation of key technologies. Development of new bone and oral implants, biodegradable stent is suitable for people of artificial joints, fast trace wound repair materials for more than 20 major products, access to more than 50 key patents.
Focus on medical imaging, medical electronics, minimally invasive, radiation therapy, laser therapy and other high-end medical equipment research, development and production of about 15 high-end products, cultivating more than 20 with strong independent innovation capacity of the backbone enterprises.
Improve population health as the main content Myson
"Planning" make great efforts to strengthen the people's livelihood technology. Among them, health and national health, clinical / translational medical research, medicine, food and livelihood security four technology demonstration focused content accounted for 50% of the project.
In the clinical / translational medical research, it is necessary to the human incidence and high mortality of major disease-focused. In Chinese medicine, Chinese herbal medicine to make breakthroughs standardized planting, quality standards for Chinese medicine granules, the material efficacy of traditional Chinese medicine research and quality evaluation of Chinese medicine and other key technologies. Focusing on more than 100 varieties of Chinese herbal medicines commonly used in Chinese medicine to carry out research and standardized planting more than 10 varieties of large-depth development of Chinese herbal medicines, to carry out eight to 10 varieties of new drug research and development, 30 varieties of traditional Chinese medicine, the second major development, promote 3 one to five varieties of traditional Chinese medicine to enter the international market.
In food safety, to enhance risk monitoring and assessment, food contamination detection technology and high-tech research and development equipment; to carry out from farm to table food safety and technology demonstration; promote the establishment of food safety emergencies interchange network monitoring and early warning information system.
Stem cell basic research and strive to achieve a major breakthrough in five years.
"Planning", the state will vigorously promote the implementation of protein research, development and reproductive research, stem cell research six major research programs strive to achieve a major breakthrough in the next five years. Focusing on non-communicable chronic complex disease mechanisms and prevention, pathogenesis and prevention of infectious diseases, family planning and reproductive health, disaster medicine, China's different ethnic susceptibility to disease, aging and aging-related diseases, traditional Chinese medicine, people with environment interactions and other areas of basic research.
Will focus on developing next-generation sequencing and genomics technology, proteomics, stem cell technology; great efforts to develop diagnostic reagents, vaccines, primate animal models of disease and blood products, tissue engineering technology and products; the establishment of gene sequencing, proteomics science, translational medicine and other R & D platforms, antibody libraries and vaccines R & D base.
|
